Quantitative CMV analysis by Real Time PCR is used to determine the amount of cytomegalovirus (CMV) in blood samples. CMV is considered a common virus that may be harmless in healthy individuals, but it poses a significant risk to people with weakened immune systems, such as organ transplant recipients or individuals infected with human immunodeficiency virus. This analysis provides accurate information about viral load, helping physicians assess the need for treatment and monitor patient response. Real Time PCR technology is effective in early detection of the virus and in identifying changes in its levels over time, contributing to improved healthcare management.